Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 107

    1.

    Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets.

    Kappelle PJ, Dallinga-Thie GM, Dullaart RP; for the Diabetes Atorvastatin Lipid Intervention (DALI) study group.

    Biochim Biophys Acta. 2009 Oct 2. [Epub ahead of print]PMID: 19800983 [PubMed - as supplied by publisher]Related articles

    2.

    Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.

    van Haperen R, Samyn H, van Gent T, Zonneveld AJ, Moerland M, Grosveld F, Jansen H, Dallinga-Thie GM, van Tol A, de Crom R.

    Biochim Biophys Acta. 2009 Oct;1791(10):1031-6. Epub 2009 Jun 11.PMID: 19524061 [PubMed - in process]Related articles

    3.

    Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.

    Kappelle PJ, Zwang L, Huisman MV, Banga JD, Sluiter WJ, Dallinga-Thie GM, Dullaart RP.

    Expert Opin Ther Targets. 2009 Jul;13(7):743-51.PMID: 19505224 [PubMed - indexed for MEDLINE]Related articles

    4.

    A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients.

    Plat J, Brufau G, Dallinga-Thie GM, Dasselaar M, Mensink RP.

    J Nutr. 2009 Jun;139(6):1143-9. Epub 2009 Apr 29.PMID: 19403719 [PubMed - indexed for MEDLINE]Related articles

    5.

    Antiproteinuric therapy decreases LDL-cholesterol as well as HDL-cholesterol in non-diabetic proteinuric patients: relationships with cholesteryl ester transfer protein mass and adiponectin.

    Krikken JA, Waanders F, Dallinga-Thie GM, Dikkeschei LD, Vogt L, Navis GJ, Dullaart RP.

    Expert Opin Ther Targets. 2009 May;13(5):497-504.PMID: 19397474 [PubMed - indexed for MEDLINE]Related articles

    6.

    Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes.

    van Hoek M, Dallinga-Thie GM, Steyerberg EW, Sijbrands EJ.

    Eur J Hum Genet. 2009 Nov;17(11):1386-93. Epub 2009 Apr 15.PMID: 19367320 [PubMed - in process]Related articles

    7.

    Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.

    Beigneux AP, Franssen R, Bensadoun A, Gin P, Melford K, Peter J, Walzem RL, Weinstein MM, Davies BS, Kuivenhoven JA, Kastelein JJ, Fong LG, Dallinga-Thie GM, Young SG.

    Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):956-62. Epub 2009 Mar 19.PMID: 19304573 [PubMed - indexed for MEDLINE]Related articles

    8.

    Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein.

    Dallinga-Thie GM, van Tol A, Dullaart RP; Diabetes Atorvastatin lipid intervention (DALI) study group.

    Biochim Biophys Acta. 2009 Aug;1791(8):714-8. Epub 2009 Mar 19.PMID: 19303940 [PubMed - indexed for MEDLINE]Related articles

    9.

    Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.

    van Hoek M, van Tol A, van Vark-van der Zee LC, Jansen H, Kastelein JJ, Sijbrands EJ, Dallinga-Thie GM.

    Curr Med Res Opin. 2009 Jan;25(1):93-101.PMID: 19210142 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.

    Birjmohun RS, Kees Hovingh G, Stroes ES, Hofstra JJ, Dallinga-Thie GM, Meijers JC, Kastelein JJ, Levi M.

    Clin Ther. 2008 Dec;30(12):2314-23.PMID: 19167590 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of different methods to investigate postprandial lipaemia.

    van Oostrom AJ, Alipour A, Sijmonsma TP, Verseyden C, Dallinga-Thie GM, Plokker HW, Castro Cabezas M.

    Neth J Med. 2009 Jan;67(1):13-20.PMID: 19155542 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.

    Vaessen SF, Dallinga-Thie GM, Ross CJ, Splint LJ, Castellani LW, Rensen PC, Hayden MR, Schaap FG, Kuivenhoven JA.

    J Lipid Res. 2009 May;50(5):880-4. Epub 2009 Jan 13.PMID: 19141870 [PubMed - indexed for MEDLINE]Related articles

    13.

    Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.

    Koeijvoets KC, Mooijaart SP, Dallinga-Thie GM, Defesche JC, Steyerberg EW, Westendorp RG, Kastelein JJ, van Hagen PM, Sijbrands EJ.

    Eur Heart J. 2009 Mar;30(5):618-23. Epub 2008 Dec 19.PMID: 19098018 [PubMed - indexed for MEDLINE]Related articles

    14.

    Fasting and postprandial remnant-like particle cholesterol concentrations in obese participants are associated with plasma triglycerides, insulin resistance, and body fat distribution.

    van Hees AM, Saris WH, Dallinga-Thie GM, Hul GB, Martinez JA, Oppert JM, Stich V, Astrup A, Arner P, Sørensen TI, Blaak EE.

    J Nutr. 2008 Dec;138(12):2399-405.PMID: 19022964 [PubMed - indexed for MEDLINE]Related articles

    15.

    ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia.

    Koeijvoets KC, van der Net JB, Dallinga-Thie GM, Steyerberg EW, Mensink RP, Kastelein JJ, Sijbrands EJ, Plat J.

    Atherosclerosis. 2009 Jun;204(2):453-8. Epub 2008 Sep 27.PMID: 18977479 [PubMed - indexed for MEDLINE]Related articles

    16.

    Renin-angiotensin-aldosterone responsiveness to low sodium and blood pressure reactivity to angiotensin-II are unrelated to cholesteryl ester transfer protein mass in healthy subjects.

    Krikken JA, Dallinga-Thie GM, Navis G, Dullaart RP.

    Expert Opin Ther Targets. 2008 Nov;12(11):1321-8.PMID: 18851690 [PubMed - indexed for MEDLINE]Related articles

    17.

    Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice.

    Weinstein MM, Yin L, Beigneux AP, Davies BS, Gin P, Estrada K, Melford K, Bishop JR, Esko JD, Dallinga-Thie GM, Fong LG, Bensadoun A, Young SG.

    J Biol Chem. 2008 Dec 12;283(50):34511-8. Epub 2008 Oct 8. Erratum in: J Biol Chem. 2009 Feb 6;284(6):4040. PMID: 18845532 [PubMed - indexed for MEDLINE]Related articles

    18.

    Reduced leucocyte cholesteryl ester transfer protein expression in acute coronary syndromes.

    Ye D, Kraaijeveld AO, Grauss RW, Willems SM, van Vark-van der Zee LC, de Jager SC, Jauhiainen M, Kuivenhoven JA, Dallinga-Thie GM, Atsma DE, Hogendoorn PC, Biessen EA, Van Berkel TJ, Jukema JW, van Eck M.

    J Intern Med. 2008 Dec;264(6):571-85. Epub 2008 Sep 6.PMID: 18783479 [PubMed - indexed for MEDLINE]Related articles

    19.

    The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.

    Olijhoek JK, Hajer GR, van der Graaf Y, Dallinga-Thie GM, Visseren FL.

    J Cardiovasc Pharmacol. 2008 Aug;52(2):145-50.PMID: 18670365 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.

    Westerveld HE, Hoogendoorn M, de Jong AW, Goverde AJ, Fauser BC, Dallinga-Thie GM.

    Pharmacol Ther. 2008 Sep;119(3):223-41. Epub 2008 Jun 17. Review.PMID: 18602948 [PubMed - indexed for MEDLINE]Related articles

    21.

    The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients.

    Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, Visseren FL.

    Atherosclerosis. 2009 Jan;202(1):216-24. Epub 2008 Apr 26.PMID: 18533158 [PubMed - indexed for MEDLINE]Related articles

    22.

    An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.

    Pullinger CR, Aouizerat BE, Movsesyan I, Durlach V, Sijbrands EJ, Nakajima K, Poon A, Dallinga-Thie GM, Hattori H, Green LL, Kwok PY, Havel RJ, Frost PH, Malloy MJ, Kane JP.

    J Lipid Res. 2008 Aug;49(8):1846-54. Epub 2008 Apr 25.PMID: 18441017 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Gene-load score of the renin-angiotensin-aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia.

    van der Net JB, van Etten J, Yazdanpanah M, Dallinga-Thie GM, Kastelein JJ, Defesche JC, Koopmans RP, Steyerberg EW, Sijbrands EJ.

    Eur Heart J. 2008 Jun;29(11):1370-6. Epub 2008 Apr 14.PMID: 18413308 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.

    Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, Olijhoek JK, Visseren FL.

    Clin Endocrinol (Oxf). 2008 Dec;69(6):870-7. Epub 2008 Apr 3.PMID: 18394022 [PubMed - indexed for MEDLINE]Related articles

    25.

    Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development.

    Dallinga-Thie GM, Dullaart RP, van Tol A.

    Curr Diab Rep. 2008 Feb;8(1):65-70. Review.PMID: 18367001 [PubMed - indexed for MEDLINE]Related articles

    26.

    Haplotype of the angiotensinogen gene is associated with coronary heart disease in familial hypercholesterolemia.

    van der Net JB, Isaacs A, Dallinga-Thie GM, Kastelein JJ, Defesche JC, Steyerberg EW, Sijbrands EJ.

    J Hypertens. 2008 Mar;26(3):462-7.PMID: 18300856 [PubMed - indexed for MEDLINE]Related articles

    27.

    Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis.

    Berbée JF, van der Hoogt CC, de Haas CJ, van Kessel KP, Dallinga-Thie GM, Romijn JA, Havekes LM, van Leeuwen HJ, Rensen PC.

    Intensive Care Med. 2008 May;34(5):907-11. Epub 2008 Jan 30.PMID: 18231776 [PubMed - indexed for MEDLINE]Related articles

    28.

    The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.

    Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.

    Curr Med Res Opin. 2008 Mar;24(3):685-94. Epub 2008 Jan 25.PMID: 18226326 [PubMed - indexed for MEDLINE]Related articles

    29.

    The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the -629C-->A cholesteryl ester transfer protein promoter polymorphism: role of lecithin: cholesterol acyltransferase activity.

    Borggreve SE, de Vries R, Dallinga-Thie GM, Wolffenbuttel BH, Groen AK, van Tol A, Dullaart RP.

    Biochim Biophys Acta. 2008 Jan-Feb;1781(1-2):10-5. Epub 2007 Dec 15.PMID: 18178167 [PubMed - indexed for MEDLINE]Related articles

    30.

    Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol.

    Dullaart RP, Groen AK, Dallinga-Thie GM, de Vries R, Sluiter WJ, van Tol A.

    Eur J Endocrinol. 2008 Jan;158(1):53-60.PMID: 18166817 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.

    van Acker BA, Botma GJ, Zwinderman AH, Kuivenhoven JA, Dallinga-Thie GM, Sijbrands EJ, Boer JM, Seidell JC, Jukema JW, Kastelein JJ, Jansen H, Verhoeven AJ; REGRESS Study Group.

    Atherosclerosis. 2008 Sep;200(1):161-7. Epub 2007 Dec 27.PMID: 18164013 [PubMed - indexed for MEDLINE]Related articles

    32.

    A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.

    Valkenburg O, Steegers-Theunissen RP, Smedts HP, Dallinga-Thie GM, Fauser BC, Westerveld EH, Laven JS.

    J Clin Endocrinol Metab. 2008 Feb;93(2):470-6. Epub 2007 Dec 4.PMID: 18056772 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Apolipoprotein A-II is inversely associated with risk of future coronary artery disease.

    Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA, Stroes ES, Otvos JD, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM.

    Circulation. 2007 Oct 30;116(18):2029-35. Epub 2007 Oct 8.PMID: 17923573 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.

    Dullaart RP, de Vries R, Dallinga-Thie GM, Sluiter WJ, van Tol A.

    Clin Endocrinol (Oxf). 2008 Mar;68(3):375-81. Epub 2007 Sep 18.PMID: 17877759 [PubMed - indexed for MEDLINE]Related articles

    35.

    Appraisal of hepatic lipase and lipoprotein lipase activities in mice.

    Dallinga-Thie GM, Zonneveld-de Boer AJ, van Vark-van der Zee LC, van Haperen R, van Gent T, Jansen H, De Crom R, van Tol A.

    J Lipid Res. 2007 Dec;48(12):2788-91. Epub 2007 Sep 13.PMID: 17872590 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.

    de Haan W, van der Hoogt CC, Westerterp M, Hoekstra M, Dallinga-Thie GM, Princen HM, Romijn JA, Jukema JW, Havekes LM, Rensen PC.

    Atherosclerosis. 2008 Mar;197(1):57-63. Epub 2007 Sep 14.PMID: 17868678 [PubMed - indexed for MEDLINE]Related articles

    37.

    The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.

    Dullaart RP, Borggreve SE, Hillege HL, Dallinga-Thie GM.

    Scand J Clin Lab Invest. 2008;68(2):99-105. Epub 2007 Jul 10.PMID: 17852818 [PubMed - indexed for MEDLINE]Related articles

    38.

    Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol.

    Bergheanu SC, Van Tol A, Dallinga-Thie GM, Liem A, Dunselman PH, Van der Bom JG, Jukema JW.

    Curr Med Res Opin. 2007 Sep;23(9):2235-40.PMID: 17692153 [PubMed - indexed for MEDLINE]Related articles

    39.

    Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression.

    van der Hoogt CC, de Haan W, Westerterp M, Hoekstra M, Dallinga-Thie GM, Romijn JA, Princen HM, Jukema JW, Havekes LM, Rensen PC.

    J Lipid Res. 2007 Aug;48(8):1763-71. Epub 2007 May 24.PMID: 17525476 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo.

    Dullaart RP, Dallinga-Thie GM, van Tol A.

    Clin Endocrinol (Oxf). 2007 Aug;67(2):316-7; author reply 317. Epub 2007 May 24. No abstract available. PMID: 17524037 [PubMed - indexed for MEDLINE]Related articles

    41.

    Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins.

    Dallinga-Thie GM, Dullaart RP, van Tol A.

    Curr Opin Lipidol. 2007 Jun;18(3):251-7. Review.PMID: 17495597 [PubMed - indexed for MEDLINE]Related articles

    42.

    High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.

    Borggreve SE, Hillege HL, Dallinga-Thie GM, de Jong PE, Wolffenbuttel BH, Grobbee DE, van Tol A, Dullaart RP; PREVEND Study Group.

    Eur Heart J. 2007 Apr;28(8):1012-8. Epub 2007 Apr 4.PMID: 17409111 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.

    de Vries R, Groen AK, Perton FG, Dallinga-Thie GM, van Wijland MJ, Dikkeschei LD, Wolffenbuttel BH, van Tol A, Dullaart RP.

    Atherosclerosis. 2008 Feb;196(2):733-41. Epub 2007 Feb 1.PMID: 17275009 [PubMed - indexed for MEDLINE]Related articles

    44.

    Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes.

    Willemsen JM, Westerink JW, Dallinga-Thie GM, van Zonneveld AJ, Gaillard CA, Rabelink TJ, de Koning EJ.

    J Cardiovasc Pharmacol. 2007 Jan;49(1):6-12.PMID: 17261957 [PubMed - indexed for MEDLINE]Related articles

    45.

    High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia.

    de Graaf J, van der Vleuten GM, ter Avest E, Dallinga-Thie GM, Stalenhoef AF.

    J Clin Endocrinol Metab. 2007 Apr;92(4):1269-75. Epub 2007 Jan 16.PMID: 17227806 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    CETP inhibition in cardiovascular risk management: a critical appraisal.

    Dullaart RP, Dallinga-Thie GM, Wolffenbuttel BH, van Tol A.

    Eur J Clin Invest. 2007 Feb;37(2):90-8. Review. Erratum in: Eur J Clin Invest. 2007 May;37(5):434. PMID: 17217373 [PubMed - indexed for MEDLINE]Related articles

    47.

    Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians.

    van der Steeg WA, Hovingh GK, Klerkx AH, Hutten BA, Nootenboom IC, Levels JH, van Tol A, Dallinga-Thie GM, Zwinderman AH, Kastelein JJ, Kuivenhoven JA.

    J Lipid Res. 2007 Mar;48(3):674-82. Epub 2006 Dec 27.PMID: 17192423 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Plasma cholesteryl ester transfer protein mass and phospholipid transfer protein activity are associated with leptin in type 2 diabetes mellitus.

    Dullaart RP, de Vries R, Dallinga-Thie GM, van Tol A, Sluiter WJ.

    Biochim Biophys Acta. 2007 Jan;1771(1):113-8. Epub 2006 Nov 15. Erratum in: Biochim Biophys Acta. 2007 Apr;1771(4):564. PMID: 17185032 [PubMed - indexed for MEDLINE]Related articles

    49.

    Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.

    van der Vleuten GM, Isaacs A, Zeng WW, ter Avest E, Talmud PJ, Dallinga-Thie GM, van Duijn CM, Stalenhoef AF, de Graaf J.

    Biochim Biophys Acta. 2007 Jan;1772(1):81-8. Epub 2006 Oct 26.PMID: 17157483 [PubMed - indexed for MEDLINE]Related articles

    50.

    Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.

    Westerterp M, van der Hoogt CC, de Haan W, Offerman EH, Dallinga-Thie GM, Jukema JW, Havekes LM, Rensen PC.

    Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2552-9. Epub 2006 Aug 31.PMID: 16946130 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...